Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings

California Nanotechnologies arranges $750,000 placement

CNO · Price

Executive Summary

  • California Nanotechnologies Corp. announced a non-brokered private placement of up to 2.5 million units at $0.30 per unit, targeting gross proceeds of up to $750,000.
  • The offering includes an overallotment option for an additional 1 million units, which would generate an extra $300,000 in gross proceeds.
  • Proceeds are intended for general working capital and corporate purposes, subject to regulatory approvals including TSX Venture Exchange consent.

Key Details

  • Offering Structure: Non-brokered private placement of units.
  • Price: $0.30 USD per unit.
  • Base Offering Size: Up to 2.5 million units.
  • Gross Proceeds (Base): Up to $750,000.
  • Overallotment Option: Allows for the sale of an additional 1 million units.
  • Additional Gross Proceeds (Overallotment): Up to $300,000.
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant is exercisable for one additional common share at an exercise price of $0.30 USD.
  • Warrant Expiry: 18 months from the closing of the offering.
  • Use of Proceeds: General working capital and corporate purposes.
  • Insider Participation: Expected to be up to 20% of the offering.
  • Regulatory Status: Subject to receipt of all necessary regulatory approvals, including TSX Venture Exchange approval.
  • Related Party Transaction: Insider participation will be treated as a related party transaction under TSX-V and MI 61-101 policies. The company anticipates relying on exemptions from minority shareholder approval and formal valuation requirements.
  • Fees: Finders' fees may be payable in connection with the offering.
Read the original news release →

More from California Nanotechnologies Corp